REGISTER NOW FOR CANCER PROGRESS 2022!

May 10-12, 2022 // VIRTUAL

Since 1989, Cancer Progress is the only oncology conference that facilitates discussions of scientific progress within the context of development, regulatory, clinical, commercial and investment perspectives over three days of provocative, informative panel discussions. The conference will feature pivotal topics, frank discussions, vigorous debate, opportunities for audience questions and comments, and a partnering platform to enable meaningful connections and meetings with innovators, developers and investors.

Our 33rd Annual Meeting on May 10-12, 2022 will provide an unsurpassed learning experience for participants in quality of information, coverage of issues, and value of professional contacts. The quality of the speaking faculty is a major contributor to the popularity and value of this conference.

CLICK TO REGISTER

CANCER PROGRESS CONFERENCE 2022 PANEL SNEAK PEAK

Patients Front and Center

How to Catch and Treat Cancer Early

The Latest Potential “Paradigm-Shifters”

ADC “The Next Generation”

Biotechs to Go It Alone –  Launch Strategy for Success

Biotech versus Pharma Perspectives – Clinical Development Strategy

Does RNA Rule the World?

Growing Pains – Navigating the Precipitous Path Towards Commercialization

Tortoises and Hares – De-risking Strategies Towards Multiplexed Candidates

Selling the Cell – Cost-benefit Considerations for Complex Therapeutics

 

Click the download button below to view the panel recordings from Cancer Progress 2021.

2022 AGENDA
DOWNLOAD

Cello Health is a global organization providing seamless consulting, insights, and communications, solutions to business challenges facing developers of pharmaceutical and biotechnology assets and brands.

Cello Health BioConsulting is a knowledge-based consultancy deeply rooted in science and the unique and ever-evolving challenges and opportunities facing the biopharma industry. Cello Health BioConsulting provides strategic advice for corporate growth and partnering strategies, disease area selection, indication prioritization, early market access strategy and early value profile development. Cello Health BioConsulting is known for “unconventional insight” – forward thinking, independent, objective and actionable strategic advice to realize value across all therapeutic areas and stages of development.

Cancer Progress by Cello Health
25-B Hanover Road, Suite 320
Florham Park, NJ 07932
Eileen Tuma, Conference Organizer
cellohealthbioconsulting.com | cancerprogress.live | cellohealth.com

linkedin twitter

Unsubscribe